We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$489B
AUM Growth
+$8.01B
Cap. Flow
-$30B
Cap. Flow %
-6.13%
Top 10 Hldgs %
29.25%
Holding
15,615
New
1,894
Increased
5,212
Reduced
6,339
Closed
1,910

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.71B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$613M
3
AAPL icon
Apple
AAPL
+$478M
4
MA icon
Mastercard
MA
+$450M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$424M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Financials 2.35%
3 Healthcare 2.22%
4 Consumer Discretionary 2.21%
5 Communication Services 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPTT icon
13501
CALL
Ocean Power Technologies
OPTT
$55.9M
$16K ﹤0.01%
10,600
-12,400
-54% -$24.1K
DYNT
13502
DELISTED
Dynatronics Corp
DYNT
$16K ﹤0.01%
3,173
-906
-22% -$5.91K
ELOX
13503
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$16K ﹤0.01%
559
-2,048
-79% -$89.3K
GSQD.WS
13504
DELISTED
G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
GSQD.WS
$16K ﹤0.01%
18,248
-341,673
-95% -$381K
EVOK
13505
DELISTED
Evoke Pharma
EVOK
$15K ﹤0.01%
185
-91
-33% -$12.7K
FENG
13506
CALL
Phoenix New Media
FENG
$18.1M
$15K ﹤0.01%
2,950
-3,083
-51% -$21.7K
JAGX icon
13507
PUT
Jaguar Health
JAGX
$4.5M
0
DVLT
13508
CALL
Datavault AI
DVLT
$272M
$15K ﹤0.01%
1
PHCF
13509
DELISTED
Puhui Wealth Investment Management Co., Ltd.
PHCF
$15K ﹤0.01%
+1,680
New +$16.5K
ELOX
13510
CALL
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$15K ﹤0.01%
543
-437
-45% -$19K
AMPE
13511
PUT
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$15K ﹤0.01%
88
-34
-28% -$12.7K
TYME
13512
PUT
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$15K ﹤0.01%
24,700
-59,600
-71% -$51.2K
TLMD
13513
CALL
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$15K ﹤0.01%
11,600
-3,500
-23% -$7.01K
GNCA
13514
PUT
DELISTED
Genocea Biosciences, Inc.
GNCA
$15K ﹤0.01%
12,800
+2,300
+22% +$3.43K
CASI
13515
DELISTED
CASI Pharmaceuticals
CASI
$14K ﹤0.01%
1,788
-1,154
-39% -$11.5K
MBAI
13516
Check-Cap
MBAI
$9.63M
$14K ﹤0.01%
+144
New +$16.9K
INM icon
13517
InMed Pharmaceuticals
INM
$7.85M
$14K ﹤0.01%
22
-14
-39% -$10.8K
ITP icon
13518
CALL
IT Tech Packaging
ITP
$2.91M
$14K ﹤0.01%
5,910
-2,040
-26% -$6.87K
JG
13519
CALL
Aurora Mobile
JG
$34.2M
$14K ﹤0.01%
+675
New +$18.7K
SNGX icon
13520
Soligenix
SNGX
$8.71M
$14K ﹤0.01%
89
-819
-90% -$177K
ZKIN icon
13521
CALL
ZK International Group
ZKIN
$60.8M
$14K ﹤0.01%
1,443
-1,100
-43% -$17.6K
FRES
13522
CALL
DELISTED
Fresh2 Group Limited American Depositary Shares
FRES
$14K ﹤0.01%
+59
New +$23.5K
VCNX
13523
CALL
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$14K ﹤0.01%
61
-238
-80% -$85.8K
CPTK.WS
13524
DELISTED
Crown PropTech Acquisitions Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CPTK.WS
$14K ﹤0.01%
25,182
-87,203
-78% -$61.2K
ODT
13525
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$14K ﹤0.01%
10,397
-51,968
-83% -$123K

Similar funds

Ken Griffin's Q4 2021 Portfolio in Review

As of Q4 2021, Ken Griffin held 15,615 positions worth $489B, up 1.7% from $481B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin withdrew a net $30B in Q4 2021, closing 1,910 positions and reducing 6,339 holdings. Its most notable exit was CIMAREX ENERGY CO, an estimated $279M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 3.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ken Griffin opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $248M.

  • Ken Griffin's largest Q4 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,847,920 shares worth $248M.
  • Ken Griffin added most to Amazon in Q4 2021, an estimated $802M increase.
  • Ken Griffin's biggest Q4 2021 reduction was Tesla, cutting an estimated $1.71B.
  • Ken Griffin fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $279M.
  • Ken Griffin's ten largest holdings make up 29% of its $489B portfolio in Q4 2021.
  • Ken Griffin opened 1,894 new positions and closed 1,910 in Q4 2021.
  • Ken Griffin's portfolio value rose 1.7% quarter-over-quarter to $489B.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.